U.S. drugmaker Merck is nearing a deal worth about $10 billion to buy Verona Pharma, a company focused on therapies for lung ...

Merck will buy UK-based Verona Pharma for about $10 billion, the companies said on Wednesday, strengthening the U.S. firm's ...

Merck said it will buy Verona Pharma for $10 billion to bolster its lung-disease business and help replace the expected loss ...

Company’s New Groundbreaking Preclinical Data in NSCLC Models Provides Further Validation for SIL204's Innovative Delivery ...

Oncology Research Program (ORP) today announced new funding for advancing clinical research in Non-Small Cell Lung Cancers ...

Lung cancer, the second-most common cancer in the U.S., is often associated with smoking — but even those who have never had ...

Corticosteroids are commonly prescribed to alleviate cancer-related symptoms in patients with non-small cell lung cancer, ...

Australia has launched its first lung cancer screening program, which targets current and recent smokers with biennial ...

A new study has opened in Manchester which could improve screening and early detection of lung cancer for high-risk Hodgkin ...

DURING SCREENING SEASON, which runs from March to December, LUCAS sets off on Mondays from the cancer institute in Morgantown ...

An international study found that air pollution leads to more cancer-related genetic changes than secondhand smoke.

Exposure to a common fungal molecule can reprogram immune cells in the lungs, causing them to overreact to infection-like ...